(Updated - November 1, 2018 12:57 PM EDT)

Cantor Fitzgerald analyst Brandon Folkes downgraded Eagle Pharmaceuticals (NASDAQ: EGRX) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades

Eagle Pharmaceuticals (EGRX) PT Lowered to $64 at RBC CapitalNovember 2, 2018 7:01 AM